Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 10 | 2017 | 3605 | 0.850 |
Why?
|
| Manganese | 3 | 2014 | 58 | 0.570 |
Why?
|
| Islets of Langerhans | 2 | 2010 | 568 | 0.500 |
Why?
|
| Cardiomegaly | 2 | 2014 | 114 | 0.460 |
Why?
|
| Insulin-Secreting Cells | 2 | 2012 | 453 | 0.460 |
Why?
|
| Manganese Compounds | 1 | 2012 | 6 | 0.380 |
Why?
|
| Chlorides | 1 | 2012 | 102 | 0.360 |
Why?
|
| Calcium | 2 | 2014 | 1195 | 0.340 |
Why?
|
| Glucose | 2 | 2012 | 703 | 0.340 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 81 | 0.320 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2010 | 286 | 0.310 |
Why?
|
| Image Enhancement | 3 | 2010 | 503 | 0.300 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 642 | 0.270 |
Why?
|
| Models, Biological | 2 | 2012 | 1809 | 0.250 |
Why?
|
| Troponin I | 2 | 2004 | 27 | 0.250 |
Why?
|
| Protein Kinase C | 2 | 2004 | 267 | 0.230 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2006 | 283 | 0.200 |
Why?
|
| Myocardial Contraction | 2 | 2004 | 193 | 0.200 |
Why?
|
| Myocardium | 1 | 2006 | 578 | 0.200 |
Why?
|
| Phosphocreatine | 1 | 2002 | 15 | 0.190 |
Why?
|
| Creatine Kinase | 1 | 2002 | 51 | 0.190 |
Why?
|
| Animals | 16 | 2022 | 28864 | 0.180 |
Why?
|
| Mice | 12 | 2022 | 12682 | 0.180 |
Why?
|
| Isoenzymes | 1 | 2002 | 272 | 0.180 |
Why?
|
| Tumor Hypoxia | 1 | 2022 | 53 | 0.180 |
Why?
|
| Muscle Contraction | 1 | 2002 | 267 | 0.170 |
Why?
|
| Nanostructures | 2 | 2014 | 93 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 520 | 0.140 |
Why?
|
| Contrast Media | 2 | 2014 | 1011 | 0.140 |
Why?
|
| Rats, Inbred Lew | 2 | 2010 | 219 | 0.140 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2010 | 202 | 0.130 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2017 | 26 | 0.130 |
Why?
|
| Receptors, Prolactin | 1 | 2017 | 11 | 0.130 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2017 | 79 | 0.120 |
Why?
|
| Prostatic Hyperplasia | 1 | 2017 | 104 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 1100 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2014 | 2206 | 0.110 |
Why?
|
| Diastole | 1 | 2014 | 101 | 0.110 |
Why?
|
| Micelles | 1 | 2014 | 56 | 0.110 |
Why?
|
| Organ Size | 1 | 2014 | 370 | 0.100 |
Why?
|
| Prostate | 1 | 2017 | 433 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2570 | 0.100 |
Why?
|
| Rats | 3 | 2010 | 4071 | 0.100 |
Why?
|
| Body Weight | 1 | 2014 | 455 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 204 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 3591 | 0.100 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2013 | 12 | 0.100 |
Why?
|
| Insulin | 2 | 2010 | 1226 | 0.100 |
Why?
|
| Curcumin | 1 | 2013 | 19 | 0.100 |
Why?
|
| Perfusion | 2 | 2014 | 271 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2014 | 632 | 0.090 |
Why?
|
| Tooth Abnormalities | 1 | 2012 | 8 | 0.090 |
Why?
|
| Foot Deformities, Congenital | 1 | 2012 | 12 | 0.090 |
Why?
|
| Streptozocin | 1 | 2012 | 57 | 0.090 |
Why?
|
| Syndactyly | 1 | 2012 | 14 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 118 | 0.090 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 41 | 0.090 |
Why?
|
| Craniofacial Abnormalities | 1 | 2012 | 37 | 0.090 |
Why?
|
| Heart Rate | 1 | 2014 | 535 | 0.090 |
Why?
|
| Brain | 2 | 2013 | 2440 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 207 | 0.090 |
Why?
|
| Peptides | 1 | 2014 | 669 | 0.080 |
Why?
|
| Spin Labels | 1 | 2010 | 107 | 0.080 |
Why?
|
| Skull | 1 | 2012 | 280 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 664 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 358 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 824 | 0.080 |
Why?
|
| Materials Testing | 2 | 2007 | 96 | 0.080 |
Why?
|
| Male | 6 | 2017 | 46983 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2012 | 1152 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 2663 | 0.070 |
Why?
|
| Aluminum Oxide | 1 | 2007 | 3 | 0.060 |
Why?
|
| Immunologic Techniques | 1 | 2007 | 25 | 0.060 |
Why?
|
| Membranes, Artificial | 1 | 2007 | 39 | 0.060 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2007 | 32 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 1 | 2006 | 244 | 0.060 |
Why?
|
| Insulinoma | 1 | 2006 | 39 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 2884 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 281 | 0.060 |
Why?
|
| Cell Separation | 1 | 2006 | 200 | 0.060 |
Why?
|
| Equipment Design | 1 | 2006 | 426 | 0.060 |
Why?
|
| Gadolinium DTPA | 2 | 2017 | 239 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2004 | 1145 | 0.050 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2004 | 23 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2004 | 58 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2004 | 195 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2004 | 97 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 119 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 92 | 0.050 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2004 | 277 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 1604 | 0.050 |
Why?
|
| Misonidazole | 1 | 2022 | 19 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2002 | 16 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 271 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1946 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 612 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2022 | 191 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 217 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2854 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 354 | 0.040 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2022 | 337 | 0.040 |
Why?
|
| Kinetics | 1 | 2002 | 1475 | 0.040 |
Why?
|
| Echocardiography | 1 | 2004 | 783 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 767 | 0.040 |
Why?
|
| Heart | 1 | 2002 | 527 | 0.040 |
Why?
|
| Placental Lactogen | 1 | 2017 | 13 | 0.030 |
Why?
|
| Prolactin | 1 | 2017 | 90 | 0.030 |
Why?
|
| Hypoxia | 1 | 2022 | 695 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 135 | 0.030 |
Why?
|
| Estradiol | 1 | 2017 | 268 | 0.030 |
Why?
|
| Endocytosis | 1 | 2017 | 187 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 461 | 0.030 |
Why?
|
| Carbocyanines | 1 | 2014 | 18 | 0.030 |
Why?
|
| Injections | 1 | 2014 | 130 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 290 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2014 | 82 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2014 | 126 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2014 | 242 | 0.020 |
Why?
|
| Humans | 3 | 2017 | 97913 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2013 | 37 | 0.020 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2012 | 21 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1947 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2014 | 262 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2012 | 370 | 0.020 |
Why?
|
| Liver | 1 | 2014 | 1231 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 1306 | 0.020 |
Why?
|
| Capsules | 1 | 2007 | 39 | 0.020 |
Why?
|
| Surface Properties | 1 | 2007 | 129 | 0.020 |
Why?
|
| Complement Activation | 1 | 2007 | 88 | 0.020 |
Why?
|
| Female | 3 | 2017 | 51441 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 2638 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 382 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2002 | 10 | 0.010 |
Why?
|
| Benzophenanthridines | 1 | 2002 | 23 | 0.010 |
Why?
|
| Phenylephrine | 1 | 2002 | 30 | 0.010 |
Why?
|
| Phenanthridines | 1 | 2002 | 25 | 0.010 |
Why?
|
| Detergents | 1 | 2002 | 32 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 2002 | 18 | 0.010 |
Why?
|
| Alkaloids | 1 | 2002 | 48 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 122 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 678 | 0.010 |
Why?
|
| Actin Cytoskeleton | 1 | 2002 | 201 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 1159 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 642 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 1320 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 4389 | 0.000 |
Why?
|